(Q46658906)

24 December 2017

title

The effect of the PPARgamma ligand rosiglitazone on energy balance regulation (English)

1 reference

24 December 2017

1 reference

4

Klaas R Westerterp

1 reference

24 December 2017

author name string

Annemiek M C P Joosen

series ordinal

1

1 reference

24 December 2017

Arjen H F Bakker

series ordinal

2

1 reference

24 December 2017

Maarten J A Gering

series ordinal

3

1 reference

24 December 2017

publication date

1 May 2006

1 reference

24 December 2017

Diabetes - Metabolism: Research and Reviews

published in

1 reference

24 December 2017

volume

22

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

204-210

1 reference

24 December 2017

Assessing Impact of Weight on Quality of Life

cites work

1 reference

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

7 January 2021

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

1 reference

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

7 January 2021

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

1 reference

7 January 2021

Is weight loss possible in patients treated with thiazolidinediones? Experience with a low-calorie diet

1 reference

7 January 2021

Differentiating members of the thiazolidinedione class: a focus on safety

1 reference

7 January 2021

Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.

1 reference

7 January 2021

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

1 reference

7 January 2021

Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.

1 reference

7 January 2021

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

1 reference

7 January 2021

A dual-respiration chamber system with automated calibration

1 reference

7 January 2021

The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity

1 reference

7 January 2021

Effects of inactivity and diet composition on human energy balance

1 reference

7 January 2021

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

1 reference

7 January 2021

Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study

1 reference

7 January 2021

Fasting plasma triglyceride levels and fat oxidation predict dietary obesity in rats

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice.

1 reference

7 January 2021

The effect of rosiglitazone on overweight subjects with type 1 diabetes

1 reference

7 January 2021

Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance

1 reference

7 January 2021

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

1 reference

7 January 2021

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.592

1 reference

24 December 2017

1 reference

24 December 2017